RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.
Training and administration of epinephrine auto-injectors for anaphylaxis treatment in US schools
results from the EpiPen4Schools(®) pilot survey
Hogue, S. L., Goss, D., Hollis, K., Silvia, S., & White, M. V. (2016). Training and administration of epinephrine auto-injectors for anaphylaxis treatment in US schools: results from the EpiPen4Schools(®) pilot survey. Journal of Asthma and Allergy, 9, 109-115. https://doi.org/10.2147/jaa.s106567
Schools differed substantially in their preparedness to manage anaphylaxis, with significant disparities in staff training and permission to treat. Given the ramifications of delayed treatment, removing barriers to the recognition and treatment of anaphylactic events in schools is an important public health goal.
